Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)

<table class="fixed-width table-group" id="tab7"><tr><td><table class="table"><colgroup><col style="width:9.08em"/><col style="width:9.08em"/><col style="width:9.08em"/></colgroup><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Endpoint</td><td class="align_center">SFI (n=74)</td><td class="align_center">Placebo (n=70)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">CCE</td><td class="align_center">0 (0.00%)</td><td class="align_center">2 (2.86%)</td></tr><tr><td class="align_left"> revascularization</td><td class="align_center">0 (0.00%)</td><td class="align_center">2 (2.86%)</td></tr><tr><td class="align_left">Death incident</td><td class="align_center">0 (0.00%)</td><td class="align_center">1 (1.43%)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Comparison of CCEs between SFI and placebo groups.</div>

Evidence-Based Complementary and Alternative Medicine

tab7

Table 7

Table 7: Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 

Table 7 | Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome) 